Exosome Treatment and Hair Growth
Launched by COSMEDICIAN AP SDN BHD · Apr 8, 2025
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Norwood grade 2-3 androgenic alopecia among male Malaysians.
- • 2. Aged between 20 and 50 years.
- • 3. Demonstrated the ability to comprehend the study protocol and information provided by the investigators.
- • 4. Participants willing to give informed consent.
- Exclusion Criteria:
- • 1. Pre-existing thyroid disorders, bleeding disorders, or diabetes.
- • 2. Current use of any medical hair treatment.
- • 3. Corticosteroid or immunosuppressive drug use.
- • 4. Alopecia classified as Norwood scale 1, 4, 5, 6, 7, or cicatricial alopecia.
- • 5. Smoking.
About Cosmedician Ap Sdn Bhd
Cosmedician Ap Sdn Bhd is a pioneering clinical trial sponsor specializing in the development and commercialization of innovative skincare and medical aesthetic solutions. With a commitment to advancing dermatological research, the company collaborates with healthcare professionals and research institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. By leveraging cutting-edge technology and adhering to the highest regulatory standards, Cosmedician Ap Sdn Bhd aims to enhance patient outcomes and contribute to the evolving landscape of dermatological care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Subang Jaya, Selangor, Malaysia
Patients applied
Trial Officials
Associate Professor Dr. Edmond Ng Siah Chye
Principal Investigator
School of Healthy Ageing, Aesthetics & Regenerative Medicine, Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported